Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT06856967
Eligibility Criteria:
Inclusion Criteria:
Case patients
* Age \<12 months
* Diagnosis of LRTI (i.e., bronchiolitis and/or pneumonia) at admission
* Positive RSV PCR on nasopharyngeal swab Control patients
* Age \<12 months
* Diagnosis of LRTI (i.e., bronchiolitis and/or pneumonia) at admission
* Hospitalized for conditions other than respiratory infections
Exclusion Criteria:
* Parental refusal
* Previous immunization with Palivizumab
* Previous maternal RSV vaccine immunization during pregnancy
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
12 Months
Study:
NCT06856967
Study Brief:
Protocol Section:
NCT06856967